One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1002/hon.3164_439
Copy DOI Journal: Hematological oncology |  Publication Date: Jun 1, 2023 |
Affiliation: University of Michigan–Ann Arbor, Norton Healthcare, Medical University of Lodz, The Maria Sklodowska-Curie National Research Institute of Oncology, Swedish Medical Center, The University of Texas MD Anderson Cancer Center, AstraZeneca (United Kingdom), AstraZeneca (United States), Summit Medical Group (United States)Safety and Efficacy of Acalabrutinib, Bendamustine, and Rituximab in Patients with Treatment‐Naive or Relapsed/Refractory Mantle Cell Lymphoma: Phase Ib Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
